We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

3402:TSEToray Industries, Inc. Analysis

Data as of 2026-06-06 - not real-time

¥1,121.50

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

Toray Industries is trading in a neutral technical zone, with the 20‑day and 50‑day moving averages hugging the current price and the 14‑day RSI sitting just below the midpoint, indicating neither strong overbought nor oversold pressure. The MACD histogram has turned positive, signaling a modest bullish tilt, while volume remains stable, supporting the price level above the identified support zone. A low beta and a volatility reading that, although elevated for a 30‑day window, remains manageable suggest the stock is less sensitive to market swings, yet the price sits above the DCF‑derived fair value, implying a degree of overvaluation. On the fundamentals side, the company delivers a dividend yield comfortably above 2% with a payout ratio under 40%, pointing to sustainable cash returns.
Analyst sentiment is broadly positive, with a consensus “buy” and price targets that imply roughly a mid‑teens upside from today’s level. The balance sheet shows ample cash against a high debt load, but the low leverage ratio relative to equity and consistent operating cash flow underpin the dividend’s durability. Diversified exposure across chemicals, advanced materials, and life‑science segments cushions the business against cyclical headwinds, while global operations introduce moderate geographic and regulatory considerations.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • MACD histogram turning positive
  • Stable trading volume near support level
  • Attractive dividend yield with low payout ratio

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Analyst price targets indicating upside
  • Sustainable dividend and solid cash flow
  • Low beta and defensive positioning in a volatile market

Long Term

> 3 years
Neutral
Model confidence: 6/10

Key Factors

  • Diversified product portfolio across high‑margin segments
  • Exposure to global growth markets balanced by regulatory risk
  • Current valuation above intrinsic fair value limiting upside

Key Metrics & Analysis

Financial Health

Profit Margin3.08%
P/E Ratio21.2
ROE4.77%
ROA1.80%
Debt/Equity46.97
P/B Ratio0.9
Op. Cash Flow¥211.8B

Technical Analysis

TrendNeutral
RSI48.5
Support¥1,056.00
Resistance¥1,224.50
MA 20¥1,127.80
MA 50¥1,130.40
MA 200¥1,070.83
MACDBullish
VolumeStable
Fear & Greed Index83.02

Valuation

Fair Value¥903.01
Target Price¥1,281.25
Upside/Downside14.24%
GradeOvervalued
TypeValue
Dividend Yield2.32%

Risk Assessment

Beta0.19
Volatility38.48%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.